| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |